The impact of alcohol and illicit drugs on people with psychosis: The second Australian national survey of psychosis
- 3 April 2012
- journal article
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 46 (9), 864-878
- https://doi.org/10.1177/0004867412443900
Abstract
Objective: To provide the most up-to-date prevalence estimates of alcohol and illicit drug use among individuals with psychosis in Australia, and explore correlates associated with a lifetime diagnosis of both alcohol abuse/dependence and cannabis abuse/dependence. Method: This paper uses data from the Survey of High Impact Psychosis (SHIP), conducted as a follow-up to the first Australian National Low Prevalence (Psychotic) Disorders Study (1997–1998). The SHIP was a national study, carried out across five states, in which a sample of 1825 individuals was recruited through a two-phase sampling framework. Results: Alcohol and illicit drug use was highly prevalent for the entire sample. There were few significant differences in the prevalence or frequency of use across the diagnostic categories examined. Substantial increases in substance abuse/dependence were noted since the 1997–1998 survey (51% diagnosed with alcohol abuse/dependence, 51% with cannabis abuse/dependence and 32% with other illicit drug abuse/dependence, compared to 28%, 23% and 12% respectively, in the 1997–1998 survey by Kavanagh et al., 2004). Factors significantly associated with both lifetime alcohol and cannabis dependence included male gender, younger age, single marital status, lower educational attainment, shorter duration of illness, lifetime presence of hallucinations, higher negative syndrome score and lower body mass index (BMI). A number of other factors were found to be differentially associated with either lifetime alcohol or cannabis dependence. Conclusions: The use of alcohol and illicit substances is common among people with a psychotic illness, with a concerning upward trend in rates of substance abuse/dependence since the 1997–1998 survey. Clinicians should be aware of the potential impact of concurrent substance use and provide integrated treatment for individuals presenting with psychotic illnesses. More research and investment in new intervention programs is required.Keywords
This publication has 28 references indexed in Scilit:
- People living with psychotic illness in 2010: The second Australian national survey of psychosisAustralian & New Zealand Journal of Psychiatry, 2012
- Tobacco smoking among people living with a psychotic illness: The second Australian survey of psychosisAustralian & New Zealand Journal of Psychiatry, 2012
- Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysisSchizophrenia Bulletin, 2009
- Comorbid substance-use in schizophrenia: Relation to positive and negative symptomsSchizophrenia Research, 2006
- The diagnostic interview for psychoses (DIP): development, reliability and applicationsPsychological Medicine, 2005
- A meta-analysis of negative symptoms in dual diagnosis schizophreniaPsychological Medicine, 2005
- Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sampleSchizophrenia Research, 2004
- Psychotic Disorders in Urban Areas: An Overview of the Study on Low Prevalence DisordersAustralian & New Zealand Journal of Psychiatry, 2000
- The deficit syndrome in the DSM-IV field trial: I. Alcohol and other drug abuseSchizophrenia Research, 1996
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991